New Treatment Strategies Making an Impact in Multiple Myeloma
Presented by Mollie Moran, CNP, and Jeffrey Jones, MD, MPH
Winship Cancer Institute of Emory University, Atlanta, Georgia
Presenters’ disclosures of potential conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2017;8:285–290 |
© 2017 Harborside Press®
Even though multiple myeloma remains incurable, mean overall survival has improved dramatically as newer game-changing therapies enter the scene. At the same time, treatment decisions and the management of toxicities related to newer drug regimens are becoming more complex.
For access to the full length article, please sign in